UPDATE: Sterne Agee Downgrades Crocs on Raised Concerns, Lowered Estimates
In a report published Thursday, Sterne Agee analyst Sam Poser downgraded Crocs (NASDAQ: CROX) from Neutral to Underperform, and named a $10.00 price target.
In the report, Sterne Agee noted, “Vacate positions in CROX: There is a global senior leadership void. 3 of 5 regions have no director. CROX is selling Crosslite products to Backjoy.com. on terms that may not be at arms' length. Lowering '13/'14 EPS estimates from $1.01/ $1.33 to $0.99/$1.20.”
Crocs closed on Wednesday at $14.01.
Latest Ratings for CROX
|Nov 2016||Monness Crespi Hardt||Downgrades||Buy||Neutral|
|Aug 2016||Susquehanna||Initiates Coverage on||Neutral|
|May 2016||Sterne Agee CRT||Upgrades||Neutral||Buy|
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.